Nucleus Genomics, a company focused on integrating advanced genetic technology into fertility care, has partnered with the Southern California Reproductive Center (SCRC), a prominent fertility clinic with over 25 years of clinical leadership and multiple locations across the state, to bring its Genetic Optimization services to patients undergoing IVF. For patients at SCRC, this means access to cutting-edge analysis without having to seek out separate, specialized services.
Through the Nucleus IVF+ Network, this collaboration integrates expanded carrier screening directly into the clinic's standard care pathway. The Genetic Optimization technology can test for over 2,000 rare inherited conditions. Its advanced embryo analysis can also assess risk for common conditions such as heart disease and diabetes.
Ultimately, Nucleus Genomics’ service provides reassurance and greater control over the family-building process. The partnership also reflects a broader shift in patient expectations, as studies indicate that a significant majority of adults support the use of advanced genetic technologies during IVF.
Image Credit: Nucleus Genomics x SCRC
What's Driving This Trend
- Clinic-embedded Genomics
- Fertility providers are incorporating advanced genetic screening into routine IVF workflows, creating space for integrated platforms that simplify access to complex reproductive risk data.
- Embryo Risk Profiling
- Expanded embryo analysis is moving beyond rare inherited disorders to include polygenic risk insights for common diseases, reshaping how prospective parents evaluate reproductive choices.
- Personalized Fertility Pathways
- Patient expectations for greater control in family planning are accelerating demand for tailored fertility services that combine clinical treatment, genetic intelligence, and decision support.
Who This Affects Most
- Fertility Care
- IVF clinics are becoming hubs for advanced genomic services, opening the market for partnerships that differentiate patient experiences through more comprehensive reproductive care.
- Genetic Testing
- Rare disease screening and common condition risk assessment are converging in reproductive settings, expanding the role of genomics companies beyond standalone diagnostics.
- Digital Health
- Data-driven fertility tools are gaining relevance as patients seek clearer, more personalized guidance, positioning software-enabled platforms as important infrastructure for reproductive medicine.
